排空膀胱对输尿管通道鞘置入阻力和输尿管损伤的影响:一项前瞻性随机对照研究

李志峰, 闻俊军, 毛蕾雅芳, 等. 排空膀胱对输尿管通道鞘置入阻力和输尿管损伤的影响:一项前瞻性随机对照研究[J]. 临床泌尿外科杂志, 2023, 38(1): 5-9. doi: 10.13201/j.issn.1001-1420.2023.01.002
引用本文: 李志峰, 闻俊军, 毛蕾雅芳, 等. 排空膀胱对输尿管通道鞘置入阻力和输尿管损伤的影响:一项前瞻性随机对照研究[J]. 临床泌尿外科杂志, 2023, 38(1): 5-9. doi: 10.13201/j.issn.1001-1420.2023.01.002
LI Zhifeng, WEN Junjun, MAO Leiyafang, et al. Effect of bladder emptying on ureteral access sheath insertion resistance and ureteral injury: a prospective randomized controlled trail[J]. J Clin Urol, 2023, 38(1): 5-9. doi: 10.13201/j.issn.1001-1420.2023.01.002
Citation: LI Zhifeng, WEN Junjun, MAO Leiyafang, et al. Effect of bladder emptying on ureteral access sheath insertion resistance and ureteral injury: a prospective randomized controlled trail[J]. J Clin Urol, 2023, 38(1): 5-9. doi: 10.13201/j.issn.1001-1420.2023.01.002

排空膀胱对输尿管通道鞘置入阻力和输尿管损伤的影响:一项前瞻性随机对照研究

  • 基金项目:
    国家自然科学基金(No:82170777);广东省自然科学基金(No:2021A1515011119)
详细信息

Effect of bladder emptying on ureteral access sheath insertion resistance and ureteral injury: a prospective randomized controlled trail

More Information
  • 目的 评估排空膀胱对输尿管通道鞘(UAS)置入阻力和输尿管损伤的影响,以指导UAS置入过程中减少输尿管损伤。方法 80例输尿管软镜碎石患者在置鞘前随机分组,分别排空膀胱和不干预,使用IMADA-50N测力计及配套软件测量并记录UAS置入时的阻力,评估输尿管损伤分级,比较2组置鞘平均阻力、全程最大阻力、分段最大阻力、输尿管损伤情况等。结果 排空膀胱组在置鞘平均阻力、置鞘最大阻力、输尿管下段置鞘最大阻力上均显著低于未排空膀胱组(P < 0.001)。横向对比中,BMI≥25 kg/m2的患者在置鞘平均阻力、置鞘最大阻力、下段最大组力上均高于BMI < 25 kg/m2的患者(P < 0.05);而男性和女性以及年龄≥50岁和年龄 < 50岁患者的5项置鞘阻力比较,差异均无统计学意义。排空膀胱组PULS 1~2级输尿管损伤发生率低于未排空膀胱组(35% vs 55%,P=0.045),差异主要体现在输尿管下段(22.5% vs 55%,P=0.006),输尿管中段及上段损伤差异无统计学意义(P>0.05)。结论 置入UAS前排空膀胱,可有效降低UAS置入阻力和输尿管下段损伤风险。
  • 加载中
  • 表 1  2组患者一般资料  例(%),X±S

    指标 排空膀胱组(40例) 未排空膀胱组(40例) P
    年龄/岁 45.9±13.3 43.3±12.5 0.356
    男/女 26/14 23/17 0.646
    BMI/(kg·m-2) 22.1±3.3 23.4±4.0 0.127
    结石直径/mm 13.2±4.2 13.1±4.4 0.938
    结石面积/mm2 198.9±92.5 230.2±98.1 0.146
    结石位置 0.436
        肾盂 13(32.5) 8(20.0)
        肾盏 10(25.0) 11(27.5)
        多发 17(42.5) 21(52.5)
    术前血红蛋白/(g·L-1) 126.4±17.3 129.5±14.3 0.388
    术前血肌酐/(μmol·L-1) 83.7±18.6 89.7±21.5 0.184
    术前尿常规阳性 15(37.5) 18(45.0) 0.650
    术前尿培养阳性 5(12.5) 6(15.0) 1.000
    高血压 14(35.0) 12(30.0) 0.811
    糖尿病 5(12.5) 9(22.5) 0.380
    下载: 导出CSV

    表 2  2组患者术中置鞘阻力比较  N,X±S

    指标 排空膀胱组(40例) 未排空膀胱组(40例) P
    平均阻力 3.12±0.49 4.28±0.52 < 0.001
    最大阻力 5.17±0.72 6.39±0.96 < 0.001
    输尿管上段最大阻力 4.94±0.86 5.01±0.81 0.685
    输尿管中段最大阻力 4.14±0.86 4.15±0.82 0.957
    输尿管下段最大阻力 3.07±0.75 6.18±1.17 < 0.001
    下载: 导出CSV

    表 3  性别对置鞘力的影响  N,X±S

    指标 男性(49例) 女性(31例) P
    平均阻力 3.60±0.79 3.85±0.71 0.148
    最大阻力 5.69±1.09 5.93±0.97 0.328
    输尿管上段最大阻力 4.97±0.90 4.99±0.74 0.931
    输尿管中段最大阻力 4.04±0.86 4.31±0.79 0.171
    输尿管下段最大阻力 4.44±1.85 4.91±1.85 0.273
    下载: 导出CSV

    表 4  年龄对置鞘力的影响  N,X±S

    指标 年龄≥50岁(28例) 年龄 < 50岁(52例) P
    置鞘平均阻力 3.64±0.92 3.73±0.68 0.632
    置鞘最大阻力 5.73±1.17 5.81±0.98 0.737
    输尿管上段最大阻力 4.92±0.80 5.01±0.86 0.659
    输尿管中段最大阻力 4.09±0.92 4.17±0.79 0.654
    输尿管下段最大阻力 4.59±1.99 4.64±1.79 0.901
    下载: 导出CSV

    表 5  BMI对置鞘力的影响  N,X±S

    指标 BMI≥25 kg/m2(18例) BMI < 25 kg/m2(62例) P
    置鞘平均阻力 4.10±0.63 3.58±0.77 0.010
    置鞘最大阻力 6.26±1.02 5.65±1.02 0.028
    输尿管上段最大阻力 5.09±0.72 4.94±0.87 0.527
    输尿管中段最大阻力 4.25±0.87 4.11±0.83 0.533
    输尿管下段最大阻力 5.56±1.70 4.35±1.81 0.013
    下载: 导出CSV

    表 6  2组患者输尿管损伤及术后结果比较  例(%),X±S

    指标 排空膀胱组(40例) 未排空膀胱组(40例) P
    输尿管损伤分级 0.045
        PULS 0 26(65.0) 18(45.0)
        PULS 1 12(30.0) 13(32.5)
        PULS 2     2(5.0) 9(22.5)
    输尿管上段损伤 14(35.0) 15(37.5) 1.000
    输尿管中段损伤 11(27.5) 13(32.5) 0.810
    输尿管下段损伤 9(22.5) 22(55.0) 0.006
    碎石时间/min 23.0±11.3 23.9±10.6 0.729
    术后血红蛋白/(g·L-1) 126.1±17.1 128.9±13.9 0.421
    术后血红蛋白下降量/(g·L-1) 0.3±1.2 0.6±1.9 0.481
    术后血肌酐/(μmol·L-1) 85.3±17.9 90.4±20.2 0.229
    结石清除 33(82.5) 32(80.0) 1.000
    术后疼痛评分 0.377
        BCS 3 9(22.5) 5(12.5)
        BCS 4 31(77.5) 35(87.5)
    术后发热 8(20.0) 4(10.0) 0.348
    术后脓毒症发生 0(0)     1(2.5) 1.000
    术后住院天数/d 0.9±0.4 0.8±0.5 0.964
    下载: 导出CSV
  • [1]

    Türk C, Petřík A, Sarica K, et al. EAU Guidelines on Interventional Treatment for Urolithiasis[J]. Eur Urol, 2016, 69(3): 475-482. doi: 10.1016/j.eururo.2015.07.041

    [2]

    De Coninck V, Keller EX, Rodríguez-Monsalve M, et al. Systematic review of ureteral access sheaths: facts and myths[J]. BJU Int, 2018, 122(6): 959-969. doi: 10.1111/bju.14389

    [3]

    阮磊. 对输尿管软镜鞘在输尿管软镜碎石术中引起的并发症的诊疗分析[J]. 浙江创伤外科, 2017, 22(5): 876-877. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJCW201705026.htm

    [4]

    Kaler KS, Lama DJ, Safiullah S, et al. Ureteral Access Sheath Deployment: How Much Force Is Too Much? Initial Studies with a Novel Ureteral Access Sheath Force Sensor in the Porcine Ureter[J]. J Endourol, 2019, 33(9): 712-718. doi: 10.1089/end.2019.0211

    [5]

    Koo KC, Lee KS, Min GR, et al. Efficacy and Safety of Ultrasonic Longitudinal-Axis Vibration for the Reduction of Ureteral Access Sheath Insertion Force: A Randomized Controlled Trial in a Porcine Model[J]. J Endourol, 2019, 33(2): 140-145. doi: 10.1089/end.2018.0772

    [6]

    Tefik T, Buttice S, Somani B, et al. Impact of ureteral access sheath force of insertion on ureteral trauma: In vivo preliminary study with 7 patients[J]. Ulus Travma Acil Cerrahi Derg, 2018, 24(6): 514-520.

    [7]

    Schoenthaler M, Buchholz N, Farin E, et al. The Post-Ureteroscopic Lesion Scale(PULS): a multicenter video-based evaluation of inter-rater reliability[J]. World J Urol, 2014, 32(4): 1033-1040. doi: 10.1007/s00345-013-1185-1

    [8]

    Abrahams HM, Stoller ML. The argument against the routine use of ureteral access sheaths[J]. Urol Clin North Am, 2004, 31(1): 83-87. doi: 10.1016/S0094-0143(03)00085-5

    [9]

    Loftus CJ, Ganesan V, Traxer O, et al. Ureteral Wall Injury with Ureteral Access Sheaths: A Randomized Prospective Trial[J]. J Endourol, 2020, 34(9): 932-936. doi: 10.1089/end.2018.0603

    [10]

    Traxer O, Thomas A. Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery[J]. J Urol, 2013, 189(2): 580-584. doi: 10.1016/j.juro.2012.08.197

    [11]

    Lildal SK, Sørensen FB, Andreassen KH, et al. Histopathological correlations to ureteral lesions visualized during ureteroscopy[J]. World J Urol, 2017, 35(10): 1489-1496. doi: 10.1007/s00345-017-2035-3

    [12]

    Shnorhavorian M, Anderson KR. Anatomic and physiologic considerations in ureteroscopy[J]. Urol Clin North Am, 2004, 31(1): 15-20. doi: 10.1016/S0094-0143(03)00090-9

    [13]

    Fahmy O, Shsm H, Lee C, et al. Impact of Preoperative Stenting on the Outcome of Flexible Ureterorenoscopy for Upper Urinary Tract Urolithiasis: A Systematic Review and Meta-Analysis[J]. Urol Int, 2022, 106(7): 679-687. doi: 10.1159/000518160

    [14]

    Law YXT, Teoh JYC, Castellani D, et al. Role of pre-operative ureteral stent on outcomes of retrograde intra-renal surgery(RIRS): systematic review and meta-analysis of 3831 patients and comparison of Asian and non-Asian cohorts[J]. World J Urol, 2022, 40(6): 1377-1389. doi: 10.1007/s00345-022-03935-2

    [15]

    Koo KC, Yoon JH, Park NC, et al. The Impact of Preoperative alpha-Adrenergic Antagonists on Ureteral Access Sheath Insertion Force and the Upper Limit of Force Required to Avoid Ureteral Mucosal Injury: A Randomized Controlled Study[J]. J Urol, 2018, 199(6): 1622-1630. doi: 10.1016/j.juro.2017.09.173

  • 加载中
计量
  • 文章访问数:  1402
  • PDF下载数:  439
  • 施引文献:  0
出版历程
收稿日期:  2022-08-04
刊出日期:  2023-01-06

目录